Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-676-3 | CAS number: 590-28-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.96 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 25
- Dose descriptor starting point:
- NOAEL
- Value:
- 60 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 74 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Using a conservative approach, a worker DNEL (long-term inhalation exposure) is derived.
Relevant dose descriptor (NOAEL): 60 mg/kg bw/day
Standard respiratory volume, human (sRVhuman) for 8 h per person (70 kg): 6.7 m3
Standard respiratory volume of the rat (sRVrat) for 8 hours: 0.38 m3/kg bw
Worker respiratory volume (wRV) for 8 hours with light physical activity per person: 10 m3
Oral absorption of the rat/ inhalation absorption of humans (ABS oral-rat / ABS inh-human): 1/2 (default)
Correction for difference between human and experimental exposure conditions: 7 d rat/5 d worker
Corrected NOAEC (inhalation) for workers:
NOAECcorr = NOAELoral x 1/0.38 m³/kg bw/day x 6.7 m³/10m³ x 7d/5d x ABSoral/ABSinh
NOAECcorr = 60 mg/kg bw/day x (1/0.38 m³/kg bw/day) x (6.7 m³/10 m³) x (7 days/ 5 days) x 0.5
NOAECcorr = 74 mg/m³
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 2
- Justification:
- The default factor for the differences between sub-chronic and chronic exposure duration is used.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- No allometric scaling factor is applied because an oral-to-inhalation route extrapolation is performed
- AF for other interspecies differences:
- 2.5
- Justification:
- Recommended AF for other interspecies differences.
- AF for intraspecies differences:
- 5
- Justification:
- The default value for the relatively homogenous group "worker" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 8.9 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 3
- DNEL extrapolated from long term DNEL
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3.36 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 100
- Dose descriptor starting point:
- NOAEL
- Value:
- 60 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 336 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Using a conservative approach, a worker DNEL (long-term dermal exposure) is derived. Based on the physico-chemical properties of potassium cyanate especially its high hydrophilicity (log Kow: <0.3 and water solubility: 750 g/L) dermal absorption is considered to be 25% of oral absorption.
Correction for difference between human and experimental exposure conditions: 7 d rat/5 d worker
Corrected NOAEL (dermal) for workers:
NOAELcorr = NOAELoral x 7d/5d x ABSoral/ABSdermal
NOAELcorr = 60 mg/kg bw/day x 1.4 x 4
NOAELcorr = 336 mg/kg bw/day
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 2
- Justification:
- The default factor for the differences between sub-chronic and chronic exposure duration is used.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- The default allometric scaling factor for the differences between rats and humans is used.
- AF for other interspecies differences:
- 2.5
- Justification:
- Recommended AF for other interspecies differences.
- AF for intraspecies differences:
- 5
- Justification:
- The default value for the relatively homogenous group "worker" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - workers
General
DNEL derivation for the test item is performed under consideration of the recommendations of ECHA (see references below).
Workers- Hazard via inhalation route
Long term, systemic DNEL
Occupational exposure to potassium cyanate occurs mainly by dermal route and may also occur by inhalation exposure. Therefore, a long-term DNEL for inhalation exposure was calculated for workers.
Step 1: Selection of the relevant dose descriptor (starting point):
An EOGRTS according to OECD TG 443 (2022) is selected for DNEL derivation as it is the relevant repeated dose study performed in accordance with OECD guideline and GLP. In this study, the oral NOAEL in rats is 60 mg/kg bw/day.
Step 2: Modification into a correct starting point:
Using a conservative approach, a worker DNEL (long-term inhalation exposure) is derived.
Relevant dose descriptor (NOAEL): 60 mg/kg bw/day
Standard respiratory volume, human (sRVhuman) for 8 h per person (70 kg): 6.7 m3
Standard respiratory volume of the rat (sRVrat) for 8 hours: 0.38 m3/kg bw
Worker respiratory volume (wRV) for 8 hours with light physical activity per person: 10 m3
Oral absorption of the rat/ inhalation absorption of humans (ABS oral-rat / ABS inh-human): 1/2 (default)
Correction for difference between human and experimental exposure conditions: 7 d rat/5 d worker
Corrected NOAEC (inhalation) for workers:
NOAECcorr = NOAELoral x 1/0.38 m³/kg bw/day x 6.7 m³/10m³ x 7d/5d x ABSoral/ABSinh
NOAECcorr = 60 mg/kg bw/day x 0.5 x (1/0.38 m³/kg bw/day) x (6.7 m³/10 m³) x (7 days/ 5 days)
NOAECcorr = 60 mg/kg bw/day x 0.5 x 2.63 x 0.67 m³ x 1.4
NOAECcorr = 74 mg/m³
Step 3: Use of assessment factors: 25
Intraspecies AF (worker): 5
The default value for the relatively homogenous group "worker" is used.
Interspecies AF, remaining differences: 2.5
The recommended AF for other interspecies differences is applied.
Allometric scaling AF: 1
No allometric scaling is applied for inhalation as the inhalative data is standardized with reference to the respiratory rates. Respiratory rates depend directly on caloric demand, therefore inhalative study results are already extrapolated to humans on the basis of metabolic rate scaling (=allometric scaling).
Dose response relationship AF: 1
The dose response relationship is considered unremarkable, therefore no additional factor is used.
Exposure duration AF: 2
Extrapolation from subchronic to chronic exposure.
Whole database AF: 1
The OECD TG 443 toxicity study was conducted according to regulatory standards and was adequately reported. On this basis the quality of the database is not considered to contribute uncertainty and it is therefore not necessary to apply an additional factor.
AF for remaining uncertainties: 1
DNEL Derivation is considered conservative, reflecting reasonable worst-case assumptions. Therefore, no further AF for remaining uncertainties is applied.
In conclusion, long term systemic inhalation DNEL = 2.96 mg/m3
Short term, systemic DNEL
No study for acute inhalation toxicity is available. As the substance is classified for acute oral toxicity, Cat. 4, an acute inhalation toxicity cannot be excluded and an acute inhalation DNEL is derived for precautionary reasons. The acute inhalation DNEL was calculated as 3 times the value of the corresponding long-term DNEL (ECHA CSR R.8, 2012).
Short term, systemic inhalation DNEL: 3 x 2.96 = 8.9 mg/m3
Acute/long term DNEL for local effects
Potassium cyanate causes eye irritation and may also lead to irritation in the mucous membrane of the respiratory tract. Therefore, a qualitative assessment is conducted.
Appropriate qualitative risk managements measures should be implemented to avoid exposure. The substance is assigned to the low hazard band in accordance with ECHA Guidance on information requirements and chemical safety assessment Part E: Risk Characterisation (2016).
Worker- Hazard via dermal route
Long term, systemic DNEL
Occupational exposure to potassium cyanate occurs mainly by dermal route and may also occur by inhalation exposure. Therefore, a long-term DNEL for dermal exposure was calculated for workers.
Step 1: Selection of the relevant dose descriptor (starting point):
An EOGRTS according to OECD TG 443 (2022) is selected for DNEL derivation as it is the relevant repeated dose study performed in accordance with OECD guideline and GLP. In this study, the oral NOAEL in rats is 51 mg/kg bw/day.
Step 2: Modification of the starting point:
Using a conservative approach, a worker DNEL (long-term dermal exposure) is derived. Based on the physico-chemical properties of potassium cyanate especially its high hydrophilicity (log Kow: <0.3 and water solubility: 750 g/L) dermal absorption is considered to be 25% of oral absorption.
Correction for difference between human and experimental exposure conditions: 7 d rat/5 d worker
Corrected NOAEL (dermal) for workers:
NOAELcorr = NOAELoral x 7d/5d x ABSoral/ABSdermal
NOAELcorr = 60 mg/kg bw/day x 1.4 x 4
NOAELcorr = 336 mg/kg bw/day
Step 3: Use of assessment factors: 100
Intraspecies AF (worker): 5
The default value for the relatively homogenous group "worker" is used.
Interspecies AF, remaining differences: 2.5
The recommended AF for other interspecies differences is applied.
Allometric scaling AF: 4
The default allometric scaling factor for the differences between rats and humans is applied.
Dose response relationship AF: 1
The dose response relationship is considered unremarkable, therefore no additional factor is used.
Exposure duration AF: 2
Extrapolation from subchronic to chronic exposure.
Whole database AF: 1
The OECD 443 study was conducted according to regulatory standards and was adequately reported. On this basis the quality of the database is not considered to contribute uncertainty and it is therefore not necessary to apply an additional factor.
AF for remaining uncertainties: 1
DNEL Derivation is considered conservative, reflecting reasonable worst-case assumptions. Therefore, no further AF for remaining uncertainties is applied.
In conclusion, long term systemic dermal DNEL = 3.36 mg/kg bw/day
Short term, systemic DNEL
Potassium cyanate is not classified for acute dermal toxicity according to Regulation (EC) 1272/2008 (CLP). Therefore, no hazard assessment was conducted and no DNEL was derived.
Acute/long term DNEL for local effects
Potassium cyanate is not classified for skin irritation and skin sensitisation according to Regulation (EC) No 1272/2008 (CLP) based on the available experimental data. Therefore, no hazard assessment was conducted.
Workers- Hazard for the eyes
Potassium cyanate is classified for eye irritation, Cat. 2 according to Regulation (EC) No 1272/2008 (CLP), based on the results of the eye irritation studies available. The substance is assigned to the low hazard band in accordance with ECHA Guidance on information requirements and chemical safety assessment Part E: Risk Characterisation (2016) and a qualitative risk assessment was conducted.
References
(Not included as endpoint study record)
- ECHA (2012). Guidance on information requirements and chemical safety assessment. Chapter R.8: Characterisation of dose [concentration]-response for human health.
- ECHA (2014). Guidance on information requirements and chemical safety assessment. Chapter R.7c: Endpoint specific guidance, Guidance on Toxicokinetics.
- ECHA (2012) Practical Guide 15: How to undertake a qualitative human health assessment and document it in a chemical safety report, November 2012.
- ECHA (2016). Guidance on Information Requirements and Chemical Safety Assessment Part E: Risk Characterisation.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
General
General population is not intended to be exposed to Potassium cyanate via inhalation or dermal route. Therefore, no DNEL (long-term, inhalation and dermal exposure) is derived for general population. As Potassium cyanate has no bioaccumulation potential no risk assessment for secondary poisoning is required for the general population.
References
(not included as endpoint study record)
- ECHA (2012) Guidance on information requirements and chemical safety assessment. Chapter R.8: Characterisation of dose [concentration]-response for human health. Version 2.1 ECHA-2010-G-19-EN.
- ECHA (2011) Guidance on information requirements and chemical safety assessment. Part B: Hazard assessment. Version 2 ECHA-11-G-16-EN
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.